Inventor

DONG HANQING

US57 patents

⚠️ This page may combine multiple inventors who share the name “DONG HANQING”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

DONG HANQING

ARVINAS OPERATIONS INC

Compounds and methods for the targeted degradation of androgen receptor

Tetrahydronaphthalene and tetrahydroisoquinoline derivatives as estrogen receptor degraders

Tetrahydronaphthalene and tetrahydroisoquinoline derivatives as estrogen receptor degraders

Compounds and methods for the targeted degradation of androgen receptor

Tetrahydronaphthalene and tetrahydroisoquinoline derivatives as estrogen receptor degraders

Compounds and methods for the targeted degradation of rapidly accelerated Fibrosarcoma polypeptides

Indazole based compounds and associated methods of use

Compounds and methods for the targeted degradation of androgen receptor

Compounds and methods for the targeted degradation of androgen receptor

Modulators of estrogen receptor proteolysis and associated methods of use

Modulators of proteolysis and associated methods of use

Modulators of alpha-synuclein proteolysis and associated methods of use

Compounds and methods for the targeted degradation of androgen receptor

Methods of manufacturing a bifunctional compound, ultrapure forms of the bifunctional compound, and dosage forms comprising the same

MDM2-based modulators of proteolysis and associated methods of use

Modulators of proteolysis and associated methods of use

Compounds and methods for the targeted degradation of androgen receptor

Compounds and methods for the targeted degradation of androgen receptor

Modulators of estrogen receptor proteolysis and associated methods of use

Cereblon ligands and bifunctional compounds comprising the same

Compounds and methods for the targeted degradation of bromodomain- containing proteins

Tetrahydronaphthalene and tetrahydroisoquinoline derivatives as estrogen receptor degraders

Compounds and methods for the targeted degradation of rapidly accelerated fibrosarcoma polypeptides

Compounds and methods for the targeted degradation of enhancer of zeste homolog 2 polypeptide

Compounds and methods for the targeted degradation of bromodomain-containing proteins

Tank-binding kinase-1 PROTACs and associated methods of use

Indole derivatives as estrogen receptor degraders

Modulators of alpha-synuclein proteolysis and associated methods of use

Compounds and methods for the enhanced degradation of targeted proteins

Compounds and methods for the enhanced degradation of targeted proteins

Indazole based compounds and associated methods of use

Cereblon-based KRAS degrading PROTACs and uses related thereto

Cereblon ligands and bifunctional compounds comprising the same

Modulators of BCL6 proteolysis and associated methods of use

ARVINAS INC

Tetrahydronaphthalene and tetrahydroisoquinoline derivatives as estrogen receptor degraders

Compounds and methods for the targeted degradation of bromodomain-containing proteins

Compounds and methods for the enhanced degradation of targeted proteins

Compounds and methods for the targeted degradation of rapidly accelerated fibrosarcoma polypeptides

Compounds and methods for the targeted degradation of androgen receptor

Modulators of estrogen receptor proteolysis and associated methods of use

Tau-protein targeting PROTACs and associated methods of use

OSI PHARM INC

Fused bicyclic mTor inhibitors

6,6-bicyclic ring substituted heterobicyclic protein kinase inhibitors

Substituted pyrrolo[2.3-B]pyridines

OSI PHARMACEUTICALS LLC

Amino pyrimidine anticancer compounds

7-aminofuropyridine derivatives

UNIV YALE

Estrogen-related receptor alpha based protac compounds and associated methods of use

ARNOLD LEE D

6,6-bicyclic ring substituted heterobicyclic protein kinase inhibitors

APPARI RAMA DEVI

Amino pyrimidine anticancer compounds

CASTELHANO ARLINDO

(Arylamidoaryl) cyanoguanidine compounds